Shanghai Wanye Enterprises Co.,Ltd (SHA:600641)
China · Delayed Price · Currency is CNY 14.68
+0.18 (1.24%)
Aug 5, 2025, 2:45 PM CST
Marinus Pharmaceuticals Revenue
Shanghai Wanye Enterprises Co.,Ltd had revenue of 192.39M CNY in the quarter ending March 31, 2025, with 94.09% growth. This brings the company's revenue in the last twelve months to 674.69M, down -28.18% year-over-year. In the year 2024, Shanghai Wanye Enterprises Co.,Ltd had annual revenue of 581.43M, down -39.72%.
Revenue (ttm)
674.69M
Revenue Growth
-28.18%
P/S Ratio
19.80
Revenue / Employee
1.03M
Employees
654
Market Cap
13.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 581.43M | -383.18M | -39.72% |
| Dec 31, 2023 | 964.61M | -192.97M | -16.67% |
| Dec 31, 2022 | 1.16B | 277.67M | 31.56% |
| Dec 31, 2021 | 879.91M | -51.58M | -5.54% |
| Dec 31, 2020 | 931.49M | -937.34M | -50.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition